Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Riffo-Vasquez (London, United Kingdom), V. Kanabar-Raivadera (London, United Kingdom), V. Corrigall (London, United Kingdom), C. Page (London, United Kingdom). TNFAIP3/A20 expression in allergic asthma. 2372

Member's Comments

No comment yet.

Related content which might interest you: New aspects of the IL-4-receptor alpha-chain lymphocyte expression in allergic and non-allergic asthma Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010 New aspects of the action of IL-4 on the activity of the transcription factor STAT6 in allergic and non-allergic asthma Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009 GATA-3 or T-bet: Who is the crucial marker of allergic bronchial asthma Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 High-level expression of PD-L1 by DC suppresses airway inflammation in OVA-induced allergic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Induced sputum levels of soluble receptor ST-2 in adult patients suffering from allergic asthma or allergic rhinitis Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status? Source: International Congress 2017 – Monitoring asthma control Year: 2017 Distinct epithelial gene expression phenotypes in childhood respiratory allergy Source: Eur Respir J 2012; 39: 1197-1205 Year: 2012 Overexpression of eNOS suppresses asthmatic features in a mouse model of allergic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 28s Year: 2002 Alveolar mast cell expression of FcεRI differs between allergic asthma and rhinitis Source: Annual Congress 2011 - Mechanisms of allergic inflammation of the airways Year: 2011 Chemokine-receptor expression on allergen-specific T cells in allergic asthma and allergic bronchopulmonary aspergillosis Source: Eur Respir J 2007; 30: Suppl. 51, 372s Year: 2007 The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 Imiquimod attenuate airway inflammation and decrease the expression of TARC in allergic asthmatic mice Source: Eur Respir J 2006; 28: Suppl. 50, 224s Year: 2006 The role of mast cells in allergic, non-allergic and aspirin-induced asthma and rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 589s Year: 2005 P-selectin expression in chronic allergic airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001 Omalizumab protects against allergen-induced bronchoconstriction in patients with allergic (IgE-mediated) asthma and high baseline IgE levels Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 A decreased expression of leptin receptor may contribute to the pathogenesis of the allergic rhinitis Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 MKK3 is expressed in cells from patients with allergic asthma Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism. Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020 Transcription factor GATA-3 as a specific marker of allergic bronchial asthma Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Local cytokine profile specifics among patients with BA phenotype, associated to allergic rhinitis: allergic rhinitis and bronchial asthma. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018